TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.60nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.90nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.90nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.20nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.60nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.70nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.80nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.20nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.60nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 430nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 474nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 479nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 520nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 562nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 580nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 637nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 710nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 807nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 860nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 904nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 968nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 1.17E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.62E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.66E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.81E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 2.05E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 2.76E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.86E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.89E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetIgG receptor FcRn large subunit p51(Homo sapiens (Human))
Syntonix Pharmaceuticals
Curated by ChEMBL
Syntonix Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of IgG binding to soluble human FcRn after 5 hrs by competition ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 3.17E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.89E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.53E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.96E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.86E+3nMAssay Description:Inhibition of BRD4 (unknown origin) by biotinylated-JQ1 based AlphaScreen BRD binding assayMore data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Harvard Medical School
Curated by ChEMBL
Harvard Medical School
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of SHP2 F285S mutant (1 to 525 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using DIFMUP as substrate preincubated f...More data for this Ligand-Target Pair